DUBLIN--(BUSINESS WIRE)--The "Global Traumatic Brain Injury Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The traumatic brain injury therapeutics market growth will stand at a CAGR of close to 5% during the forecast period
The high prevalence of TBI globally is because of the increase in the number of falls, road accidents, and other causes. In most of these cases people with TBI need to be hospitalized. The prevalence of TBI among various age groups and eternal causes are important driving factors for the global TBI therapeutics market.
Array of new drug approvals
The drug development process is a long and expansive process. The number of molecules under development for the treatment of TBI is increasing at a substantial rate because of the rising prevalence of TBI globally.
Preference for substitutes
Most drugs are mostly symptomatic and not curative. The substitutes prove to be more efficient and are preferred among patients. This is expected to pose a challenge to the market.
Key Players
- Baxter
- Fresenius
- Johnson & Johnson Services
- Novartis
- Pfizer
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Anticonvulsants - Market size and forecast 2018-2023
- Anti-anxiety agents - Market size and forecast 2018-2023
- Anticoagulants - Market size and forecast 2018-2023
- Analgesics - Market size and forecast 2018-2023
- Other therapeutics - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 12: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Baxter
- Fresenius
- Johnson & Johnson Services
- Novartis
- Pfizer
For more information about this report visit https://www.researchandmarkets.com/research/k34dvs/global_traumatic?w=4
